A real-world multicenter study on left atrial appendage occlusion: The Italian multi-device experience.

Transcatheter left atrial appendage occlusion (LAAO) has emerged as an alternative treatment for stroke prevention in patients with atrial fibrillation (AF) at high risk of thromboembolism, who cannot tolerate long-term oral anticoagulation (OAC). Questions persist regarding effectiveness and safety of this treatment and the optimal post-interventional antithrombotic regimen after LAAO.

Reference: A real-world multicenter study on left atrial appendage occlusion: The Italian multi-device experience.

Go to PubMed